We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Defensins Bar Viruses from Cells

By Biotechdaily staff writers
Posted on 17 Oct 2005
Researchers have found that the defensin class of proteins protects cells from viral infection by cross-linking cell surface glycoproteins, which prevents the virus particles from binding to and fusing with the cell membrane.

Defensins comprise a family of small (30-35 residue) cysteine-rich cationic proteins primarily found in vertebrate phagocytes. More...
Investigators at the [U.S] National Institutes of Health (Bethesda, MD, USA; www.nih.gov) worked with epithelial cells from the inner surface of the lungs to study how defensins prevent viruses from entering the cells.

They reported in the October 2005 issue of Nature Immunology that defensins work in a lectin-like fashion to cross-link and immobilize glycoproteins in the cell membrane. Viruses usually cause the glycoproteins to clump together exposing areas of the membrane surface to which they can bind, fuse, and enter the cell. Defensin cross-linking locks the virus out.

"Defensins do not kill the virus, they just prevent it from entering the cell,” said senior author Dr. Leonid V. Chernomordik, head of the section on membrane biology in the laboratory of cellular and molecular biophysics at NIH. "Viruses that are not allowed to enter the cells can then be destroyed by the cells of the immune system.”



Related Links:
U.S. National Institutes of Health

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Portable POCT Blood Gas Analyzer
BD100
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.